Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Peric Popadic, Aleksandra (6603261722)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
    (2024)
    Kusic, Natasa (58304100500)
    ;
    Tomic Spiric, Vesna (6603500319)
    ;
    Arandjelovic, Snezana (19533573900)
    ;
    Peric Popadic, Aleksandra (6603261722)
    ;
    Bozic Antic, Ivana (56016978300)
    ;
    Dimitrijevic, Milan (57430798900)
    ;
    Miskovic, Rada (56394650000)
    ;
    Stefanovic, Ljiljana (57198255193)
    ;
    Plavsic, Aleksandra (24169362300)
    Background: Drug desensitization allows for safe administration of a drug to a patient with a previous hypersensitivity reaction. Successful desensitization protocols have been described for different medications, including protocols for oncology patients. Few cases of desensitization to sorafenib and imatinib have been described in the literature so far. Objective: The objective of this paper is to describe the process of the sorafenib and imatinib drug hypersensitivity diagnosis and desensitization process in two patients. Methods: Two oncology patients who experienced non-immediate hypersensitivity reactions to sorafenib and imatinib underwent desensitization to these drugs. We designed a protocol for the first patient and used a modified protocol from the literature for the second patient. Results: By using a slow desensitization technique and gradual tapering of corticosteroids and antihistamines, both patients reached the target dose of the incriminated drug. Conclusions: Desensitization to sorafenib and imatinib can be an effective therapeutic option in patients with hypersensitivity to those medications, without alternative treatment options. © 2024 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Successful Desensitization to Sorafenib and Imatinib—A Report of Two Cases and a Literature Review
    (2024)
    Kusic, Natasa (58304100500)
    ;
    Tomic Spiric, Vesna (6603500319)
    ;
    Arandjelovic, Snezana (19533573900)
    ;
    Peric Popadic, Aleksandra (6603261722)
    ;
    Bozic Antic, Ivana (56016978300)
    ;
    Dimitrijevic, Milan (57430798900)
    ;
    Miskovic, Rada (56394650000)
    ;
    Stefanovic, Ljiljana (57198255193)
    ;
    Plavsic, Aleksandra (24169362300)
    Background: Drug desensitization allows for safe administration of a drug to a patient with a previous hypersensitivity reaction. Successful desensitization protocols have been described for different medications, including protocols for oncology patients. Few cases of desensitization to sorafenib and imatinib have been described in the literature so far. Objective: The objective of this paper is to describe the process of the sorafenib and imatinib drug hypersensitivity diagnosis and desensitization process in two patients. Methods: Two oncology patients who experienced non-immediate hypersensitivity reactions to sorafenib and imatinib underwent desensitization to these drugs. We designed a protocol for the first patient and used a modified protocol from the literature for the second patient. Results: By using a slow desensitization technique and gradual tapering of corticosteroids and antihistamines, both patients reached the target dose of the incriminated drug. Conclusions: Desensitization to sorafenib and imatinib can be an effective therapeutic option in patients with hypersensitivity to those medications, without alternative treatment options. © 2024 by the authors.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback